본문 바로가기
KERD
논문KCI 등재

남성 하부요로증상 환자에서 전립선 크기가Tamsulosin의 효과에 미치는 영향

Influence of Prostate Volume in the Medical Treatment of Male LowerUrinary Tract Symptoms with Tamsulosin

이정구|김대경|배재현
대한배뇨장애요실금학회 (Korean Continence Society)|2007.06|International Neurourology Journal|제11권 제1호|pp. 54-58

0

조회

0

다운로드

0

인용

0

참고문헌

초록

Abstract

Purpose: To evaluate the influence of prostate volume on the changes of International Prostate Symptoms Score (IPSS) and other clinical parameters in men with lower urinary tract symptoms (LUTS) undergoing tamsulosin treatment. Materials and Methods: Patients were evaluated initially by IPSS/QoL questionnaire, digital rectal examination (DRE), transrectal ultrasonography (TRUS), urinalysis, serum prostate-specific antigen (PSA), maximal urine flow rate (Qmax) and post-void residual urine (PVR). Patients were grouped according to baseline prostate volume (PV): PV＜20 ml (group A), 20 ml≤PV＜30 ml (group B), 30 ml≤PV＜40 ml (group C), PV≥40 ml (group D). All the patients were given tamsulosin 0.2 mg per day. After 8 weeks of tamsulosin treatment, clinical efficacy was determined by changes of IPSS/QoL scores, Qmax and PVR volumes. Results: Overall 672 patients were enrolled initially and 580 patients have finished the protocol. After treatment, total IPSS score was decreased by 6.2 point (31.7%) and Qmax was increased by 1.8ml/sec (29.7%). When clinical outcomes were compared according to the different PV groups, there were no statistically significant differences among groups except significant Qmax changes between group B and D. Conclusion: Clinical efficacy of short term tamsulosin medication is not affected by the prostate volume. It may be necessary that the results of this study should be confirmed in further long term follow-ups. (J. Korean Continence Society 2007;11:54-58)

참고문헌 (18)

  1. "Abrams P. In support of pressure-flow studies for evaluatingmen with lower urinary tract symptoms. Urology 1994", pp.153~5
  2. "Use of 5alpha-reductase inhibitors to prevent benignprostatic hyperplasia disease", 7, pp.293~303 (2006)
  3. "Kontturi MJ. Urodynamic effects of finasteridein the treatment of bladder outlet obstruction due to benignprostatic hyperplasia. J Urol 1993", pp.342~4
  4. "Combination therapy with doxazosinand finasteride for benign prostatic hyperplasia in patients withlower urinary tract symptoms and a baseline total prostatevolume of 25 ml or greater", 175, pp.217~220 (2006)
  5. "Clinical significance of alpha1-adrenocep-tor selectivity in the management of benign prostatic hyperplasia", 33, pp.407~412 (2001)
  6. "Treatment choice for benign prostatic hyperplasia:a matter of urologist preference?", 161, pp.133~138 (1999)
  7. "Alpha1-adrenergic receptors in human spinal cord: specificlocalized expression of mRNA encoding alpha 1-adrenergicreceptor subtypes at four distinct levels", 63, pp.254~261 (1999)
  8. "Tamsulosin for treatinglower urinary tract symptoms compatible with benign prostaticobstruction: a systematic review of efficacy and adverseeffects", 167, pp.177~183 (2002)
  9. "Tamsulosin:an update of its role in the management of lower urinary tractsymptoms.", 62, pp.135~167 (2002)
  10. "Influence of prostatesize on terazosin efficacy", 4, pp.358~361 (1997)
  11. "Meta-analysis of randomized trials of terazosin in the treatmentof benign prostatic hyperplasia", 58, pp.717~722 (2001)
  12. "Drug therapy ofbenign prostatic hyperplasia syndrome with alpha 1-receptorblockers. Basic principles and clinical results", 41, pp.425~441
  13. "Effect of terazosin on clinical benignprostatic hyperplasia in older adults", 51, pp.424~426 (2003)
  14. "The response to alpha blockadein benign prostatic hyperplasia is related to the percentarea density of prostate smooth muscle", pp.297~307
  15. "Prediction of alpha-blocker response in men with benignprostatic hyperplasia by magnetic resonance imaging", 54, pp.829~833 (1999)
  16. "Yaksh TL. Micturition in the unanesthetizedrat spinal vs. peripheral pharmacology of the adrenergicsystem. J Pharmacol Exp Ther 1988", pp.426~35
  17. "The role of peripheral and spinal a1-adrenoceptorin bladder overactivity induced by partial bladder outletobstruction in rat", 41, pp.959~967 (2000)
  18. "In vitro responses of alpha-adrenergicantagonist of rat detrusor muscle after partial bladder outletobstruction", 40, pp.458~463 (1999)

관련 논문AI추천

하부요로증상을 가진 여성 환자에서 Tamsulosin 0.2mg 단독요법의 유효성권태균, 김덕윤, 박철희, 오태희, 장혁수, 정세일, 정재일대한배뇨장애요실금학회 · International Neurourology Journal2006 · 제10권 제2호전립선비대증 환자에서 Dutasteride 치료 후 혈 중 Prostate-specific antigen 치의 변화김형지, 이길호, 홍주형대한배뇨장애요실금학회 · International Neurourology Journal2008 · 제12권 제1호전립선비대증 환자에서 치료 후 야간뇨의 변화강정윤, 유탁근, 조정만대한배뇨장애요실금학회 · International Neurourology Journal2005 · 제9권 제1호Impact of Intravesical Protrusion of the Prostate in the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia of Moderate Size by Alpha Receptor Antagonist김형지, 서유미대한배뇨장애요실금학회 · International Neurourology Journal2012 · 제16권 제4호전립선비대증 환자에서 전립선용적의 예측인자로서의 전립선특이항원권준오, 김병한, 류동수, 박우진, 오태희대한배뇨장애요실금학회 · International Neurourology Journal2006 · 제10권 제2호과민성방광을 동반한 하부요로증상 환자에서알파차단제와 항콜린제 병용투여의 효과이건철, 조인래대한배뇨장애요실금학회 · International Neurourology Journal2007 · 제11권 제1호

이 간행물의 다른 논문 (14건)

만성전립선염/만성골반통증후군의치료김형지pp. 1-8전립선비대증 환자에서 경요도전립선절제술 후요도협착의 발생에 영향을 미치는 요인박봉희, 정영범, 박영경, 박종관, 박정선pp. 9-13파킨슨질환자의 요실금 실태허정식, 이은주, 강지훈, 김영주, 송효정pp. 14-18여성 복압성요실금 환자에서 동적 자기공명영상으로관찰한 Tension Free Vaginal Tape수술 전후 골반저 변화김수진, 조용현, 조강준, 손동완, 김현우, 최항원, 김두배, 김세웅, 박덕진, 김성대, 정운석pp. 19-23전립선 비대증 환자에서 항콜린성 약물다제투여 및 중추신경계 부작용 조사양상국, 김동욱, 이준민, 김홍섭, 김형지, 정홍, 홍우성pp. 24-29
원문 보기